Integral Diagnostics Limited (IDX.AX)
AUD 2.9
(-2.68%)
AUD 2.9
(-2.68%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -60.69 Million AUD | -342.41% |
| 2023 | 25.04 Million AUD | 71.47% |
| 2022 | 14.6 Million AUD | -53.3% |
| 2021 | 31.26 Million AUD | 35.75% |
| 2020 | 23.03 Million AUD | 9.77% |
| 2019 | 20.98 Million AUD | 39.15% |
| 2018 | 15.07 Million AUD | -2.59% |
| 2017 | 15.48 Million AUD | 35.93% |
| 2016 | 11.38 Million AUD | 153.07% |
| 2015 | 4.5 Million AUD | 31.44% |
| 2014 | 3.42 Million AUD | 6.0% |
| 2013 | 3.22 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -66.75 Million AUD | -849.81% |
| 2024 Q4 | 6.05 Million AUD | 109.07% |
| 2024 FY | -60.69 Million AUD | -342.41% |
| 2023 Q2 | 16.13 Million AUD | 266.5% |
| 2023 FY | 25.04 Million AUD | 71.47% |
| 2023 Q4 | 8.9 Million AUD | -44.83% |
| 2022 Q2 | 10.2 Million AUD | -10.31% |
| 2022 FY | 14.6 Million AUD | -53.3% |
| 2022 Q4 | 4.4 Million AUD | -56.83% |
| 2021 Q2 | 19.89 Million AUD | 63.71% |
| 2021 Q4 | 11.37 Million AUD | -42.84% |
| 2021 FY | 31.26 Million AUD | 35.75% |
| 2020 FY | 23.03 Million AUD | 9.77% |
| 2020 Q4 | 12.15 Million AUD | 11.7% |
| 2020 Q2 | 10.88 Million AUD | 5.33% |
| 2019 Q4 | 10.32 Million AUD | -3.05% |
| 2019 FY | 20.98 Million AUD | 39.15% |
| 2019 Q2 | 10.65 Million AUD | 56.03% |
| 2018 Q4 | 6.82 Million AUD | -17.25% |
| 2018 Q2 | 8.25 Million AUD | 21.02% |
| 2018 FY | 15.07 Million AUD | -2.59% |
| 2017 Q4 | 6.81 Million AUD | -21.29% |
| 2017 FY | 15.48 Million AUD | 35.93% |
| 2017 Q2 | 8.66 Million AUD | 13.84% |
| 2016 Q4 | 7.6 Million AUD | 101.35% |
| 2016 Q2 | 3.77 Million AUD | -48.88% |
| 2016 FY | 11.38 Million AUD | 153.07% |
| 2015 Q4 | 7.39 Million AUD | 355.6% |
| 2015 FY | 4.5 Million AUD | 31.44% |
| 2015 Q2 | -2.89 Million AUD | 0.0% |
| 2014 FY | 3.42 Million AUD | 6.0% |
| 2013 FY | 3.22 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Australian Clinical Labs Limited | 23.93 Million AUD | 353.61% |
| BCAL Diagnostics Limited | -6.4 Million AUD | -848.394% |
| Genetic Signatures Limited | -17.86 Million AUD | -239.822% |
| Genetic Technologies Limited | -12.01 Million AUD | -405.1% |
| Healius Limited | -645.8 Million AUD | 90.601% |
| Imagion Biosystems Limited | -12.47 Million AUD | -386.607% |
| INOVIQ Ltd | -6.55 Million AUD | -826.087% |
| Microba Life Sciences Limited | -19.93 Million AUD | -204.431% |
| Monash IVF Group Limited | -6.52 Million AUD | -829.968% |
| Rhythm Biosciences Limited | -6.85 Million AUD | -785.243% |
| Sonic Healthcare Limited | 511.09 Million AUD | 111.876% |